Literature DB >> 23240497

[NAD+-converting enzymes in neuronal and glial cells: CD38 as a novel target for neuroprotection].

A B Salmina, A I Inzhutova, A V Morgun, O S Okuneva, N A Malinovskaia, O L Lopatina, M M Petrova, T E Taranushenko, A A Fursov, N V Kuvacheva.   

Abstract

The review contains current data on molecular mechanisms which control NAD+ homeostasis in brain cells. It also deals with the role of NAD+-converting enzymes in regulation of functional activity, viability and intercellular communication of neuronal and glial cells. Special attention is paid to involvement of CD38 into regulation of NAD+ levels in brain cells in normal and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23240497

Source DB:  PubMed          Journal:  Vestn Ross Akad Med Nauk        ISSN: 0869-6047


  3 in total

Review 1.  Endothelial Progenitor Cells Physiology and Metabolic Plasticity in Brain Angiogenesis and Blood-Brain Barrier Modeling.

Authors:  Natalia A Malinovskaya; Yulia K Komleva; Vladimir V Salmin; Andrey V Morgun; Anton N Shuvaev; Yulia A Panina; Elizaveta B Boitsova; Alla B Salmina
Journal:  Front Physiol       Date:  2016-12-01       Impact factor: 4.566

2.  Designing in vitro Blood-Brain Barrier Models Reproducing Alterations in Brain Aging.

Authors:  Elena D Osipova; Yulia K Komleva; Andrey V Morgun; Olga L Lopatina; Yulia A Panina; Raissa Ya Olovyannikova; Elizaveta F Vais; Vladimir V Salmin; Alla B Salmina
Journal:  Front Aging Neurosci       Date:  2018-08-06       Impact factor: 5.750

Review 3.  CD157 and Brain Immune System in (Patho)physiological Conditions: Focus on Brain Plasticity.

Authors:  Olga L Lopatina; Yulia K Komleva; Natalia A Malinovskaya; Yulia A Panina; Andrey V Morgun; Alla B Salmina
Journal:  Front Immunol       Date:  2020-11-10       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.